Attend the first Medical Anti-aging Business Normalization Guide of China
Chinese Association of Plastics and Aesthetics, Anti-aging Medicine Branch held a press conference in Beijing on January 23, 2016 to officially release the first Medical Anti-aging Business Normalization Guide of China (“Guide”). Haohai Biological Technology was invited to attend the conference as a leading enterprise in biological medicine industry. During the conference, representatives of enterprise management and Prof. Zhao Qiming, chairman of Chinese Association of Plastics and Aesthetics, Anti-aging Medicine Branch were interviewed by media.
Haohai Biological Technology always devotes itself to human medicine and health. According to the research report of China Food and Drug Administration (CFDA) Southern Medical Economics Institute (Southern Institute), Haohai Biological Technology was the largest manufacturer and supplier of joint cavity viscoelastic supplements, mono-phase cross-linked sodium hyaluronate gel approved by CFDA. With outstanding 3D moulding and anti-aging and lifting effect, the product is popular among doctors and people who seek beauty and has great sales performance in two years after coming into the market.
Haohai Biological Technology management gives full support to release of the Guide and will be devoted to anti-aging business normalization together with industrial organizations, authoritative experts, peer companies and even common consumers. According to information, it’s the first time for domestic industrial organizations to publicly release relevant normalization guidance document. The Guide will have a powerful impact on business normalization.
Company News